Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07091526

Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer

Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province

View on ClinicalTrials.gov

Summary

This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.

Official title: Whether Controlling Serum Uric Acid (SUA) Can Benefit Postoperative Survival in Patients With Pancreatic Cancer

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

168

Start Date

2025-07-29

Completion Date

2026-12-29

Last Updated

2025-12-19

Healthy Volunteers

No

Conditions

Interventions

DIAGNOSTIC_TEST

serum uric acid test

Detect the serum uric acid in blood sample

Locations (1)

Hepatopancreatobiliary Surgery Institute of Gansu Province

Lanzhou, Gansu, China